KRAS/NRAS Mutations Associated with Distant Metastasis and BRAF/PIK3CA Mutations Associated with Poor Tumor Differentiation in Colorectal Cancer

KRAS/NRAS Mutations Associated with Distant Metastasis and BRAF/PIK3CA Mutations Associated with Poor Tumor Differentiation in Colorectal Cancer

Juanzi Zeng,1,2 Wenwei Fan,3 Jiaquan Li,1,2 Guowu Wu,1,2 Heming Wu2 1Department of Medical Oncology, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China; 2Center for Precision Medicine, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Me...

Full description

Bibliographic Details
Main Authors:	Zeng J, Fan W, Li J, Wu G, Wu H
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-09-01
Series:	International Journal of General Medicine
Subjects:	colorectal cancer kras nras braf pik3ca clinicopathological feature
Online Access:	https://www.dovepress.com/krasnras-mutations-associated-with-distant-metastasis-and-brafpik3ca-m-peer-reviewed-fulltext-article-IJGM

Similar Items

Significance of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer patients receiving Bevacizumab: a single institution experience
by: Edita Baltruškevičienė, et al.
Published: (2016-04-01)

Mutational profile of KRAS, NRAS, BRAF, PIK3CA, and AKT1 genes in colorectal cancer patients in a tertiary care hospital, Dhaka
by: Sharmin Chowdhury, et al.
Published: (2022-10-01)

Clinicopathological Characteristics of Colorectal Cancer Patients with Different Mismatch Repair Statuses and Their Correlation with KRAS/NRAS/BRAF Gene Mutations
by: Jinchuan YU, et al.
Published: (2024-11-01)

KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
by: Sergiu Pasca, et al.
Published: (2019-10-01)

Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
by: Aleksandra Bożyk, et al.
Published: (2021-03-01)

Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer
by: İvo Gökmen, et al.
Published: (2023-09-01)

INFLUENCE OF SOMATIC MUTATIONS OF KRAS, NRAS, BRAF AND MICROSATELLITE INSTABILITY STATUS ON SURVIVAL OF COLORECTAL CANCER PATIENTS WITH PERITONAL CARCINO
by: V. P. Shubin, et al.
Published: (2020-10-01)

Meta-analysis of clinical trials on concordance of mutational stauts of primary tumour and distant metastases of colorectal cancer
by: M. Yu. Fedyanin, et al.
Published: (2017-04-01)

Analysis of KRAS, NRAS, and BRAF Mutations, Microsatellite Instability, and Relevant Prognosis Effects in Patients With Early Colorectal Cancer: A Cohort Study in East Asia
by: Yang Li, et al.
Published: (2022-06-01)

NRAS Mutations May Be Involved in the Pathogenesis of Cutaneous Rosai Dorfman Disease: A Pilot Study
by: Kuan-Jou Wu, et al.
Published: (2021-05-01)

KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer – practical implications for the clinician
by: Afrăsânie Vlad-Adrian, et al.
Published: (2019-09-01)

Using tumor habitat-derived radiomic analysis during pretreatment 18F-FDG PET for predicting KRAS/NRAS/BRAF mutations in colorectal cancer
by: Hongyue Zhao, et al.
Published: (2024-02-01)

Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma
by: Moltara Maja Ebert, et al.
Published: (2018-04-01)

Study on relationship between genetic abnormalities and clinicopathological features in K hospital's patients with colorectal cancer
by: Linh Dieu Vuong, et al.
Published: (2022-08-01)

Prevalence of <it>KRAS</it>, <it>BRAF</it>, and <it>PIK3CA</it> somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia
by: Palomba Grazia, et al.
Published: (2012-08-01)

The combination of mutations in BRAF and NRAS genes within a one tumor in patients with cutaneous melanoma
by: M. B. Aksenenko, et al.
Published: (2019-10-01)

The role of KRAS and NRAS mutation detection in determining the therapy strategy for colorectal cancer
by: A. N. Toropovskiy, et al.
Published: (2022-11-01)

Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis
by: Nianyi Li, et al.
Published: (2023-07-01)

NRAS and KRAS polymorphisms are not associated with hepatoblastoma susceptibility in Chinese children
by: Tianyou Yang, et al.
Published: (2019-05-01)

Copy Number Amplification of the PIK3CA Gene Is Associated with Poor Prognosis in Non-lymph node metastatic Head and Neck Squamous Cell Carcinoma
by: Suda Toshihito, et al.
Published: (2012-09-01)

The Prevalence of BRAF, PIK3CA, and RAS Mutations in Indian Patients with Colorectal Cancer
by: Omshree Shetty, et al.
Published: (2022-07-01)

Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care
by: Markus V. Heppt, et al.
Published: (2017-08-01)

<i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Hot-Spot Mutations in Relation to Sidedness of Primary Colorectal Cancer: A Retrospective Cohort Study
by: Omer Abdelgadir, et al.
Published: (2025-01-01)

FREQUENCY OF NRAS AND KRAS GENES IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS
by: Sidra Barlas, et al.
Published: (2020-04-01)

Many Distinct Ways Lead to Drug Resistance in <i>BRAF</i>- and <i>NRAS</i>-Mutated Melanomas
by: Jiri Vachtenheim, et al.
Published: (2021-05-01)

Mortality Outcome Associated with Specific <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Hot-Spot Mutations in Metastatic Colorectal Cancer Patients: A Retrospective Cohort Study
by: Omer Abdelgadir, et al.
Published: (2025-02-01)

Evaluation of EGFR, KRAS and BRAF gene mutations in renal cell carcinoma
by: Omer Bayrak, et al.
Published: (2014-08-01)

Relationship between KRAS and NRAS factors with clinicopathologic findings in patients with metastatic colon cancer
by: Hamid Saeidi Saedi, et al.
Published: (2023-03-01)

Somatic mutations in colorectal cancer: regional experience
by: Nikolai A. Ognerubov, et al.
Published: (2022-07-01)

BRAF, NRAS, KIT, TERT, GNAQ/GNA11 Mutation Profile and Histomorphological Analysis of Anorectal Melanomas: A Clinicopathologic Study
by: Orhun Cig TASKIN, et al.
Published: (2023-01-01)

KRAS and NRAS genes mutations as biomarkers in the therapy of colorectal cancer and the basic methods of their detection
by: Olga I. Brovkina, et al.
Published: (2021-03-01)

The prevalence of KRAS and BRAF mutation in colorectal cancer patients in Bali
by: Ayu Dewi Ni Nyoman, et al.
Published: (2022-03-01)

Analysis of EGFR, KRAS, and PIK3CA gene mutation rates and clinical distribution in patients with different types of lung cancer
by: Shuo Li, et al.
Published: (2021-07-01)

Evaluation of mutations in KRAS and BRAF genes in Iranian population with diffuse gastric cancer
by: M. Saneipour, et al.
Published: (2019-07-01)

Correlation between KRAS and NRAS mutational status and clinicopathological features in 414 cases of metastatic colorectal cancer in Morocco: the largest North African case series
by: Youssef Mahdi, et al.
Published: (2023-06-01)

Analysis of KRAS and NRAS mutations in Greek patients with metastatic Colorectal Cancer (mCRC) on the registry of the Gastro-intestinal Cancer Study Group (GIC-SG)
by: Gouvas Nikolaos, et al.
Published: (2019-07-01)

Coexistence of KRAS and BRAF Mutations in Colorectal Cancer: A case report supporting the concept of tumoral heterogeneity
by: Pegah Larki, et al.
Published: (2017-05-01)

Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancer
by: Gizem Teoman, et al.
Published: (2024-12-01)

Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing
by: Parvez M. Lokhandwala, et al.
Published: (2019-07-01)

Next generation sequencing for personalized therapy: About a class III BRAF N581K mutation associated to NRAS Q61L mutation in malignant melanoma: Case report
by: Manuel Croix, et al.
Published: (2023-08-01)